human hepatocytes aml12 Search Results


98
ATCC d animal models e
D Animal Models E, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+hepatocytes+aml12/AML12/pmc07224309__MSB___16___e9156___s010-497-2-15
Average 98 stars, based on 1 article reviews
d animal models e - by Bioz Stars, 2026-09
98/100 stars
  Buy from Supplier

94
CLS Cell Lines Service GmbH alpha mouse liver 12
Compounds 5f and 4d attenuate inflammation in vitro. Effects of compounds (10 µM) on the protein levels of STAT3, IκB, and NF-κB in <t>AML-12</t> cells. ( a ) Expression levels of inflammation related-proteins in vitro. ( b – d ) Protein expression levels were normal-ized against the indicated protein. * p < 0.05 compared with the group treated with the PBS (vehicle). + p < 0.05 compared with the group treated with the LPS. Data are pre-sented as the mean ± SD.
Alpha Mouse Liver 12, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+hepatocytes+aml12/AML12+Cells/pmc09141988-228-6-15
Average 94 stars, based on 1 article reviews
alpha mouse liver 12 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

96
ATCC mouse liver hepatocytes
Compounds 5f and 4d attenuate inflammation in vitro. Effects of compounds (10 µM) on the protein levels of STAT3, IκB, and NF-κB in <t>AML-12</t> cells. ( a ) Expression levels of inflammation related-proteins in vitro. ( b – d ) Protein expression levels were normal-ized against the indicated protein. * p < 0.05 compared with the group treated with the PBS (vehicle). + p < 0.05 compared with the group treated with the LPS. Data are pre-sented as the mean ± SD.
Mouse Liver Hepatocytes, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+hepatocytes+aml12/AML12%3B+Hepatocyte%3B+Mouse/pmc04200021-50-8-24
Average 96 stars, based on 1 article reviews
mouse liver hepatocytes - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

95
ATCC non tumorigenic aml12 mouse hepatocyte cell line
In vitro validation of the effects of the peroxisome proliferator activated receptor λ coactivator 1α (PGC-secretome) on cell viability and expression of various markers. ( A ) Effects of each secretome on the viability of <t>AML12</t> hepatocytes. Cell viability analysis revealed that the PGC-secretome increased the viability of thioacetamide (TAA)-treated AML12 hepatocytes significantly more than did the control and normal secretome. ( B ) Western blot analysis demonstrating the effects of each secretome on the expression of various markers in AML12 hepatocytes. The markers included those for liver proliferation (p-STAT3, t-STAT3, VEGF, and HGF), mitochondrial fusion (OPA-1), mitochondrial fission (DRP-1), pro-apoptosis (BIM), and anti-apoptosis (Bcl-xL). PGC-secretome significantly increased the expression of markers related to proliferation, mitochondrial fusion, and anti-apoptosis, and significantly decreased the expression of the markers related to mitochondrial fission and pro-apoptosis. Values are presented as mean ± standard deviation of three independent experiments; * p < 0.05. Abbreviations: Bcl-xL, B-cell leukemia-extra large; BIM, Bcl-2-like protein 11; Ct, control; DRP-1, dynamin related protein 1; HGF, hepatocyte growth factor; NS, normal secretome; OPA-1, Opa1 mitochondrial dynamin like GTPase; PCNA, proliferating cell nuclear antigen; PS, PGC-secretome; TAA, thioacetamide; VEGF, vascular endothelial growth factor.
Non Tumorigenic Aml12 Mouse Hepatocyte Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+hepatocytes+aml12/Pfizer+Pneumococcal+polysaccharide+powder+Type+1/pmc06888642-109-1-11
Average 95 stars, based on 1 article reviews
non tumorigenic aml12 mouse hepatocyte cell line - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

99
ATCC hepa1 6 hepatoma mus musculus mouse atcc crl 1830 aml12 hepatocyte mus musculus
In vitro validation of the effects of the peroxisome proliferator activated receptor λ coactivator 1α (PGC-secretome) on cell viability and expression of various markers. ( A ) Effects of each secretome on the viability of <t>AML12</t> hepatocytes. Cell viability analysis revealed that the PGC-secretome increased the viability of thioacetamide (TAA)-treated AML12 hepatocytes significantly more than did the control and normal secretome. ( B ) Western blot analysis demonstrating the effects of each secretome on the expression of various markers in AML12 hepatocytes. The markers included those for liver proliferation (p-STAT3, t-STAT3, VEGF, and HGF), mitochondrial fusion (OPA-1), mitochondrial fission (DRP-1), pro-apoptosis (BIM), and anti-apoptosis (Bcl-xL). PGC-secretome significantly increased the expression of markers related to proliferation, mitochondrial fusion, and anti-apoptosis, and significantly decreased the expression of the markers related to mitochondrial fission and pro-apoptosis. Values are presented as mean ± standard deviation of three independent experiments; * p < 0.05. Abbreviations: Bcl-xL, B-cell leukemia-extra large; BIM, Bcl-2-like protein 11; Ct, control; DRP-1, dynamin related protein 1; HGF, hepatocyte growth factor; NS, normal secretome; OPA-1, Opa1 mitochondrial dynamin like GTPase; PCNA, proliferating cell nuclear antigen; PS, PGC-secretome; TAA, thioacetamide; VEGF, vascular endothelial growth factor.
Hepa1 6 Hepatoma Mus Musculus Mouse Atcc Crl 1830 Aml12 Hepatocyte Mus Musculus, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+hepatocytes+aml12/Hepa+1-6/pmc00187424-139-83-88
Average 99 stars, based on 1 article reviews
hepa1 6 hepatoma mus musculus mouse atcc crl 1830 aml12 hepatocyte mus musculus - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

86
Procell Inc urine hepatocyte cell line aml12
In vitro validation of the effects of the peroxisome proliferator activated receptor λ coactivator 1α (PGC-secretome) on cell viability and expression of various markers. ( A ) Effects of each secretome on the viability of <t>AML12</t> hepatocytes. Cell viability analysis revealed that the PGC-secretome increased the viability of thioacetamide (TAA)-treated AML12 hepatocytes significantly more than did the control and normal secretome. ( B ) Western blot analysis demonstrating the effects of each secretome on the expression of various markers in AML12 hepatocytes. The markers included those for liver proliferation (p-STAT3, t-STAT3, VEGF, and HGF), mitochondrial fusion (OPA-1), mitochondrial fission (DRP-1), pro-apoptosis (BIM), and anti-apoptosis (Bcl-xL). PGC-secretome significantly increased the expression of markers related to proliferation, mitochondrial fusion, and anti-apoptosis, and significantly decreased the expression of the markers related to mitochondrial fission and pro-apoptosis. Values are presented as mean ± standard deviation of three independent experiments; * p < 0.05. Abbreviations: Bcl-xL, B-cell leukemia-extra large; BIM, Bcl-2-like protein 11; Ct, control; DRP-1, dynamin related protein 1; HGF, hepatocyte growth factor; NS, normal secretome; OPA-1, Opa1 mitochondrial dynamin like GTPase; PCNA, proliferating cell nuclear antigen; PS, PGC-secretome; TAA, thioacetamide; VEGF, vascular endothelial growth factor.
Urine Hepatocyte Cell Line Aml12, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+hepatocytes+aml12/aml12+cells/pm42106917-242-1-9
Average 86 stars, based on 1 article reviews
urine hepatocyte cell line aml12 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Servicebio Inc specialized hepatocyte maintenance medium
In vitro validation of the effects of the peroxisome proliferator activated receptor λ coactivator 1α (PGC-secretome) on cell viability and expression of various markers. ( A ) Effects of each secretome on the viability of <t>AML12</t> hepatocytes. Cell viability analysis revealed that the PGC-secretome increased the viability of thioacetamide (TAA)-treated AML12 hepatocytes significantly more than did the control and normal secretome. ( B ) Western blot analysis demonstrating the effects of each secretome on the expression of various markers in AML12 hepatocytes. The markers included those for liver proliferation (p-STAT3, t-STAT3, VEGF, and HGF), mitochondrial fusion (OPA-1), mitochondrial fission (DRP-1), pro-apoptosis (BIM), and anti-apoptosis (Bcl-xL). PGC-secretome significantly increased the expression of markers related to proliferation, mitochondrial fusion, and anti-apoptosis, and significantly decreased the expression of the markers related to mitochondrial fission and pro-apoptosis. Values are presented as mean ± standard deviation of three independent experiments; * p < 0.05. Abbreviations: Bcl-xL, B-cell leukemia-extra large; BIM, Bcl-2-like protein 11; Ct, control; DRP-1, dynamin related protein 1; HGF, hepatocyte growth factor; NS, normal secretome; OPA-1, Opa1 mitochondrial dynamin like GTPase; PCNA, proliferating cell nuclear antigen; PS, PGC-secretome; TAA, thioacetamide; VEGF, vascular endothelial growth factor.
Specialized Hepatocyte Maintenance Medium, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+hepatocytes+aml12/hepatocyte+maintenance+medium+specialized/pm41664051-103-6-12
Average 86 stars, based on 1 article reviews
specialized hepatocyte maintenance medium - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

90
ScienCell primary human hepatocytes 5200
In vitro validation of the effects of the peroxisome proliferator activated receptor λ coactivator 1α (PGC-secretome) on cell viability and expression of various markers. ( A ) Effects of each secretome on the viability of <t>AML12</t> hepatocytes. Cell viability analysis revealed that the PGC-secretome increased the viability of thioacetamide (TAA)-treated AML12 hepatocytes significantly more than did the control and normal secretome. ( B ) Western blot analysis demonstrating the effects of each secretome on the expression of various markers in AML12 hepatocytes. The markers included those for liver proliferation (p-STAT3, t-STAT3, VEGF, and HGF), mitochondrial fusion (OPA-1), mitochondrial fission (DRP-1), pro-apoptosis (BIM), and anti-apoptosis (Bcl-xL). PGC-secretome significantly increased the expression of markers related to proliferation, mitochondrial fusion, and anti-apoptosis, and significantly decreased the expression of the markers related to mitochondrial fission and pro-apoptosis. Values are presented as mean ± standard deviation of three independent experiments; * p < 0.05. Abbreviations: Bcl-xL, B-cell leukemia-extra large; BIM, Bcl-2-like protein 11; Ct, control; DRP-1, dynamin related protein 1; HGF, hepatocyte growth factor; NS, normal secretome; OPA-1, Opa1 mitochondrial dynamin like GTPase; PCNA, proliferating cell nuclear antigen; PS, PGC-secretome; TAA, thioacetamide; VEGF, vascular endothelial growth factor.
Primary Human Hepatocytes 5200, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+hepatocytes+aml12/primary+human+hepatocytes+5200/pm39032642-254-8-12
Average 90 stars, based on 1 article reviews
primary human hepatocytes 5200 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
BioResource International Inc aml12 cell line
AKR1A1 knockdown in <t>AML12</t> hepatocytes exacerbates lipid accumulation, inflammation, and fibrosis. AKR1A1 knockdown was conducted in AML12 hepatocytes by infecting cells with either a control (sh-control) or an AKR1A1-specific (sh-AKR1A1) shRNA lentiviral clone for 48 h. The shRNA-treated AML12 hepatocytes were then subjected to stimulation with a palmitic acid and oleic acid mixture (P/O) to induce steatosis in the absence or presence of 200 mM ethanol for 72 h. Afterward, western blotting and qRT‒PCR were performed to characterize AKR1A1 expression at both the protein ( A ) and mRNA ( B ) levels. ORO staining was performed to examine lipid accumulation in AML12 hepatocytes ( D ). The extent of lipid accumulation was quantified by extracting the bound ORO dye and detecting the absorbance at 450 nm ( C ). Furthermore, the related marker genes involved in FA transport and synthesis ( Cd36 , Fasn , Acaca , Cyp4a , Cyp2e1 , Lipin1 , Ppar-γ , and Srebp1 ) ( E ) and FA oxidation ( Cpt1α , Acox1 , and Pparα ) ( F ) were examined at the mRNA level. In addition, shRNA-treated AML12 hepatocytes were stimulated with 1 µg/ml of LPS to induce inflammation for 24 h and stimulated with 5 ng/ml TGF-β1 to induce fibrosis for 48 h. After the treatments, qRT‒PCT was performed to characterize the mRNA levels of inflammation-related ( Il-1b , Tnf-α ) ( G ) and fibrosis-related ( Fn1 , α-Sma , Col1a1 , and Timp-1 ) ( H ) marker genes. All values were normalized to the β-actin gene and expressed in relation to the sh-control group. Data are presented as the means ± SD ( n ≥ 3). Statistical differences were marked as follows: # p < 0.05, ## p < 0.01, ### p < 0.001 (compared with the sh-control Ctrl group); * p < 0.05, ** p < 0.01, *** p < 0.001 (compared between the other groups)
Aml12 Cell Line, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+hepatocytes+aml12/aml12+cells/pmc10837880-78-1-19
Average 90 stars, based on 1 article reviews
aml12 cell line - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Pro-cell Co Ltd aml12 (mouse immortalized hepatocytes) (cat number: cl-0007)
AKR1A1 knockdown in <t>AML12</t> hepatocytes exacerbates lipid accumulation, inflammation, and fibrosis. AKR1A1 knockdown was conducted in AML12 hepatocytes by infecting cells with either a control (sh-control) or an AKR1A1-specific (sh-AKR1A1) shRNA lentiviral clone for 48 h. The shRNA-treated AML12 hepatocytes were then subjected to stimulation with a palmitic acid and oleic acid mixture (P/O) to induce steatosis in the absence or presence of 200 mM ethanol for 72 h. Afterward, western blotting and qRT‒PCR were performed to characterize AKR1A1 expression at both the protein ( A ) and mRNA ( B ) levels. ORO staining was performed to examine lipid accumulation in AML12 hepatocytes ( D ). The extent of lipid accumulation was quantified by extracting the bound ORO dye and detecting the absorbance at 450 nm ( C ). Furthermore, the related marker genes involved in FA transport and synthesis ( Cd36 , Fasn , Acaca , Cyp4a , Cyp2e1 , Lipin1 , Ppar-γ , and Srebp1 ) ( E ) and FA oxidation ( Cpt1α , Acox1 , and Pparα ) ( F ) were examined at the mRNA level. In addition, shRNA-treated AML12 hepatocytes were stimulated with 1 µg/ml of LPS to induce inflammation for 24 h and stimulated with 5 ng/ml TGF-β1 to induce fibrosis for 48 h. After the treatments, qRT‒PCT was performed to characterize the mRNA levels of inflammation-related ( Il-1b , Tnf-α ) ( G ) and fibrosis-related ( Fn1 , α-Sma , Col1a1 , and Timp-1 ) ( H ) marker genes. All values were normalized to the β-actin gene and expressed in relation to the sh-control group. Data are presented as the means ± SD ( n ≥ 3). Statistical differences were marked as follows: # p < 0.05, ## p < 0.01, ### p < 0.001 (compared with the sh-control Ctrl group); * p < 0.05, ** p < 0.01, *** p < 0.001 (compared between the other groups)
Aml12 (Mouse Immortalized Hepatocytes) (Cat Number: Cl 0007), supplied by Pro-cell Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+hepatocytes+aml12/AML12++Mouse+immortalized+hepatocytes+++cat+number++CL+0007/pm39855028-55-10-21
Average 90 stars, based on 1 article reviews
aml12 (mouse immortalized hepatocytes) (cat number: cl-0007) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Corning Life Sciences transwell chambers with a diameter and pore size
AKR1A1 knockdown in <t>AML12</t> hepatocytes exacerbates lipid accumulation, inflammation, and fibrosis. AKR1A1 knockdown was conducted in AML12 hepatocytes by infecting cells with either a control (sh-control) or an AKR1A1-specific (sh-AKR1A1) shRNA lentiviral clone for 48 h. The shRNA-treated AML12 hepatocytes were then subjected to stimulation with a palmitic acid and oleic acid mixture (P/O) to induce steatosis in the absence or presence of 200 mM ethanol for 72 h. Afterward, western blotting and qRT‒PCR were performed to characterize AKR1A1 expression at both the protein ( A ) and mRNA ( B ) levels. ORO staining was performed to examine lipid accumulation in AML12 hepatocytes ( D ). The extent of lipid accumulation was quantified by extracting the bound ORO dye and detecting the absorbance at 450 nm ( C ). Furthermore, the related marker genes involved in FA transport and synthesis ( Cd36 , Fasn , Acaca , Cyp4a , Cyp2e1 , Lipin1 , Ppar-γ , and Srebp1 ) ( E ) and FA oxidation ( Cpt1α , Acox1 , and Pparα ) ( F ) were examined at the mRNA level. In addition, shRNA-treated AML12 hepatocytes were stimulated with 1 µg/ml of LPS to induce inflammation for 24 h and stimulated with 5 ng/ml TGF-β1 to induce fibrosis for 48 h. After the treatments, qRT‒PCT was performed to characterize the mRNA levels of inflammation-related ( Il-1b , Tnf-α ) ( G ) and fibrosis-related ( Fn1 , α-Sma , Col1a1 , and Timp-1 ) ( H ) marker genes. All values were normalized to the β-actin gene and expressed in relation to the sh-control group. Data are presented as the means ± SD ( n ≥ 3). Statistical differences were marked as follows: # p < 0.05, ## p < 0.01, ### p < 0.001 (compared with the sh-control Ctrl group); * p < 0.05, ** p < 0.01, *** p < 0.001 (compared between the other groups)
Transwell Chambers With A Diameter And Pore Size, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+hepatocytes+aml12/96+well+plates/pm39627775-84-22-25
Average 90 stars, based on 1 article reviews
transwell chambers with a diameter and pore size - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

hep g2  (ATCC)
99
ATCC hep g2
AKR1A1 knockdown in <t>AML12</t> hepatocytes exacerbates lipid accumulation, inflammation, and fibrosis. AKR1A1 knockdown was conducted in AML12 hepatocytes by infecting cells with either a control (sh-control) or an AKR1A1-specific (sh-AKR1A1) shRNA lentiviral clone for 48 h. The shRNA-treated AML12 hepatocytes were then subjected to stimulation with a palmitic acid and oleic acid mixture (P/O) to induce steatosis in the absence or presence of 200 mM ethanol for 72 h. Afterward, western blotting and qRT‒PCR were performed to characterize AKR1A1 expression at both the protein ( A ) and mRNA ( B ) levels. ORO staining was performed to examine lipid accumulation in AML12 hepatocytes ( D ). The extent of lipid accumulation was quantified by extracting the bound ORO dye and detecting the absorbance at 450 nm ( C ). Furthermore, the related marker genes involved in FA transport and synthesis ( Cd36 , Fasn , Acaca , Cyp4a , Cyp2e1 , Lipin1 , Ppar-γ , and Srebp1 ) ( E ) and FA oxidation ( Cpt1α , Acox1 , and Pparα ) ( F ) were examined at the mRNA level. In addition, shRNA-treated AML12 hepatocytes were stimulated with 1 µg/ml of LPS to induce inflammation for 24 h and stimulated with 5 ng/ml TGF-β1 to induce fibrosis for 48 h. After the treatments, qRT‒PCT was performed to characterize the mRNA levels of inflammation-related ( Il-1b , Tnf-α ) ( G ) and fibrosis-related ( Fn1 , α-Sma , Col1a1 , and Timp-1 ) ( H ) marker genes. All values were normalized to the β-actin gene and expressed in relation to the sh-control group. Data are presented as the means ± SD ( n ≥ 3). Statistical differences were marked as follows: # p < 0.05, ## p < 0.01, ### p < 0.001 (compared with the sh-control Ctrl group); * p < 0.05, ** p < 0.01, *** p < 0.001 (compared between the other groups)
Hep G2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+hepatocytes+aml12/Hep+G2/custom%40hb-8065%4032081304
Average 99 stars, based on 1 article reviews
hep g2 - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

Image Search Results


Compounds 5f and 4d attenuate inflammation in vitro. Effects of compounds (10 µM) on the protein levels of STAT3, IκB, and NF-κB in AML-12 cells. ( a ) Expression levels of inflammation related-proteins in vitro. ( b – d ) Protein expression levels were normal-ized against the indicated protein. * p < 0.05 compared with the group treated with the PBS (vehicle). + p < 0.05 compared with the group treated with the LPS. Data are pre-sented as the mean ± SD.

Journal: International Journal of Molecular Sciences

Article Title: Novel Benzoxazoles Containing 4-Amino-Butanamide Moiety Inhibited LPS-Induced Inflammation by Modulating IL-6 or IL-1β mRNA Expression

doi: 10.3390/ijms23105331

Figure Lengend Snippet: Compounds 5f and 4d attenuate inflammation in vitro. Effects of compounds (10 µM) on the protein levels of STAT3, IκB, and NF-κB in AML-12 cells. ( a ) Expression levels of inflammation related-proteins in vitro. ( b – d ) Protein expression levels were normal-ized against the indicated protein. * p < 0.05 compared with the group treated with the PBS (vehicle). + p < 0.05 compared with the group treated with the LPS. Data are pre-sented as the mean ± SD.

Article Snippet: The human keratinocytes HaCaT or the alpha mouse liver 12 (AML-12) cells were obtained from Cell Lines Service GmbH (Eppelheim, Germany).

Techniques: In Vitro, Expressing

In vitro validation of the effects of the peroxisome proliferator activated receptor λ coactivator 1α (PGC-secretome) on cell viability and expression of various markers. ( A ) Effects of each secretome on the viability of AML12 hepatocytes. Cell viability analysis revealed that the PGC-secretome increased the viability of thioacetamide (TAA)-treated AML12 hepatocytes significantly more than did the control and normal secretome. ( B ) Western blot analysis demonstrating the effects of each secretome on the expression of various markers in AML12 hepatocytes. The markers included those for liver proliferation (p-STAT3, t-STAT3, VEGF, and HGF), mitochondrial fusion (OPA-1), mitochondrial fission (DRP-1), pro-apoptosis (BIM), and anti-apoptosis (Bcl-xL). PGC-secretome significantly increased the expression of markers related to proliferation, mitochondrial fusion, and anti-apoptosis, and significantly decreased the expression of the markers related to mitochondrial fission and pro-apoptosis. Values are presented as mean ± standard deviation of three independent experiments; * p < 0.05. Abbreviations: Bcl-xL, B-cell leukemia-extra large; BIM, Bcl-2-like protein 11; Ct, control; DRP-1, dynamin related protein 1; HGF, hepatocyte growth factor; NS, normal secretome; OPA-1, Opa1 mitochondrial dynamin like GTPase; PCNA, proliferating cell nuclear antigen; PS, PGC-secretome; TAA, thioacetamide; VEGF, vascular endothelial growth factor.

Journal: International Journal of Molecular Sciences

Article Title: Enhanced Therapeutic Potential of the Secretome Released from Adipose-Derived Stem Cells by PGC-1α-Driven Upregulation of Mitochondrial Proliferation

doi: 10.3390/ijms20225589

Figure Lengend Snippet: In vitro validation of the effects of the peroxisome proliferator activated receptor λ coactivator 1α (PGC-secretome) on cell viability and expression of various markers. ( A ) Effects of each secretome on the viability of AML12 hepatocytes. Cell viability analysis revealed that the PGC-secretome increased the viability of thioacetamide (TAA)-treated AML12 hepatocytes significantly more than did the control and normal secretome. ( B ) Western blot analysis demonstrating the effects of each secretome on the expression of various markers in AML12 hepatocytes. The markers included those for liver proliferation (p-STAT3, t-STAT3, VEGF, and HGF), mitochondrial fusion (OPA-1), mitochondrial fission (DRP-1), pro-apoptosis (BIM), and anti-apoptosis (Bcl-xL). PGC-secretome significantly increased the expression of markers related to proliferation, mitochondrial fusion, and anti-apoptosis, and significantly decreased the expression of the markers related to mitochondrial fission and pro-apoptosis. Values are presented as mean ± standard deviation of three independent experiments; * p < 0.05. Abbreviations: Bcl-xL, B-cell leukemia-extra large; BIM, Bcl-2-like protein 11; Ct, control; DRP-1, dynamin related protein 1; HGF, hepatocyte growth factor; NS, normal secretome; OPA-1, Opa1 mitochondrial dynamin like GTPase; PCNA, proliferating cell nuclear antigen; PS, PGC-secretome; TAA, thioacetamide; VEGF, vascular endothelial growth factor.

Article Snippet: A non-tumorigenic AML12 mouse hepatocyte cell line (CRL-2254), was purchased from American Type Culture Collection (ATCC; Manassas, VA, USA).

Techniques: In Vitro, Biomarker Discovery, Expressing, Control, Western Blot, Standard Deviation

AKR1A1 knockdown in AML12 hepatocytes exacerbates lipid accumulation, inflammation, and fibrosis. AKR1A1 knockdown was conducted in AML12 hepatocytes by infecting cells with either a control (sh-control) or an AKR1A1-specific (sh-AKR1A1) shRNA lentiviral clone for 48 h. The shRNA-treated AML12 hepatocytes were then subjected to stimulation with a palmitic acid and oleic acid mixture (P/O) to induce steatosis in the absence or presence of 200 mM ethanol for 72 h. Afterward, western blotting and qRT‒PCR were performed to characterize AKR1A1 expression at both the protein ( A ) and mRNA ( B ) levels. ORO staining was performed to examine lipid accumulation in AML12 hepatocytes ( D ). The extent of lipid accumulation was quantified by extracting the bound ORO dye and detecting the absorbance at 450 nm ( C ). Furthermore, the related marker genes involved in FA transport and synthesis ( Cd36 , Fasn , Acaca , Cyp4a , Cyp2e1 , Lipin1 , Ppar-γ , and Srebp1 ) ( E ) and FA oxidation ( Cpt1α , Acox1 , and Pparα ) ( F ) were examined at the mRNA level. In addition, shRNA-treated AML12 hepatocytes were stimulated with 1 µg/ml of LPS to induce inflammation for 24 h and stimulated with 5 ng/ml TGF-β1 to induce fibrosis for 48 h. After the treatments, qRT‒PCT was performed to characterize the mRNA levels of inflammation-related ( Il-1b , Tnf-α ) ( G ) and fibrosis-related ( Fn1 , α-Sma , Col1a1 , and Timp-1 ) ( H ) marker genes. All values were normalized to the β-actin gene and expressed in relation to the sh-control group. Data are presented as the means ± SD ( n ≥ 3). Statistical differences were marked as follows: # p < 0.05, ## p < 0.01, ### p < 0.001 (compared with the sh-control Ctrl group); * p < 0.05, ** p < 0.01, *** p < 0.001 (compared between the other groups)

Journal: Cell & Bioscience

Article Title: Aldo-keto reductase family 1 member A1 (AKR1A1) exerts a protective function in alcohol-associated liver disease by reducing 4-HNE accumulation and p53 activation

doi: 10.1186/s13578-024-01200-0

Figure Lengend Snippet: AKR1A1 knockdown in AML12 hepatocytes exacerbates lipid accumulation, inflammation, and fibrosis. AKR1A1 knockdown was conducted in AML12 hepatocytes by infecting cells with either a control (sh-control) or an AKR1A1-specific (sh-AKR1A1) shRNA lentiviral clone for 48 h. The shRNA-treated AML12 hepatocytes were then subjected to stimulation with a palmitic acid and oleic acid mixture (P/O) to induce steatosis in the absence or presence of 200 mM ethanol for 72 h. Afterward, western blotting and qRT‒PCR were performed to characterize AKR1A1 expression at both the protein ( A ) and mRNA ( B ) levels. ORO staining was performed to examine lipid accumulation in AML12 hepatocytes ( D ). The extent of lipid accumulation was quantified by extracting the bound ORO dye and detecting the absorbance at 450 nm ( C ). Furthermore, the related marker genes involved in FA transport and synthesis ( Cd36 , Fasn , Acaca , Cyp4a , Cyp2e1 , Lipin1 , Ppar-γ , and Srebp1 ) ( E ) and FA oxidation ( Cpt1α , Acox1 , and Pparα ) ( F ) were examined at the mRNA level. In addition, shRNA-treated AML12 hepatocytes were stimulated with 1 µg/ml of LPS to induce inflammation for 24 h and stimulated with 5 ng/ml TGF-β1 to induce fibrosis for 48 h. After the treatments, qRT‒PCT was performed to characterize the mRNA levels of inflammation-related ( Il-1b , Tnf-α ) ( G ) and fibrosis-related ( Fn1 , α-Sma , Col1a1 , and Timp-1 ) ( H ) marker genes. All values were normalized to the β-actin gene and expressed in relation to the sh-control group. Data are presented as the means ± SD ( n ≥ 3). Statistical differences were marked as follows: # p < 0.05, ## p < 0.01, ### p < 0.001 (compared with the sh-control Ctrl group); * p < 0.05, ** p < 0.01, *** p < 0.001 (compared between the other groups)

Article Snippet: The AML12 cell line, which are hepatocytes isolated from the normal liver of a mouse, was purchased from the Bioresource Collection and Research Center, Hsinchu, Taiwan.

Techniques: Knockdown, Control, shRNA, Western Blot, Expressing, Staining, Marker